×
About 1,028 results

ALLMedicine™ Gastrointestinal Tumors Center

Research & Reviews  321 results

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: ...
https://doi.org/10.1097/MD.0000000000029364
Medicine Wang G, Pan L et. al.

Jun 28th, 2022 - During the coronavirus disease 2019 (COVID-19) pandemic, endoscopic screening for gastrointestinal tumors was suspended or delayed in most countries. Thus, our study aimed to quantify the impact of COVID-19 on the clinical outcomes of patients wit...

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
https://clinicaltrials.gov/ct2/show/NCT00044304

Jun 24th, 2022 - This study will evaluate the safety and effectiveness of imatinib mesylate in reducing the number of eosinophils (a type of white blood cell) in patients with hypereosinophilic syndrome (HES). Patients with HES have elevated counts of eosinophils ...

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
https://clinicaltrials.gov/ct2/show/NCT05430841

Jun 24th, 2022 - Subjects with gastrointestinal tumors underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). The numbers of...

Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy
https://clinicaltrials.gov/ct2/show/NCT05427227

Jun 22nd, 2022 - The investigators will recruit 500 advancer/late-stage gastrointestinal cancer patients.Blood and tumor tissue will be collected at treatment baseline, every time point response till disease progression. All samples will be processed by exosomes p...

Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
https://clinicaltrials.gov/ct2/show/NCT05182983

Jun 16th, 2022 - The tongue images of patients with gastrointestinal diseases and healthy people will be collected and the tongue image database will be established. Through deep learning and artificial intelligence, early screening models of various gastrointesti...

see more →

Guidelines  1 results

Endoscopic resection of superficial gastrointestinal tumors.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977951
World Journal of Gastroenterology; Marc G, Lopes CV

Aug 14th, 2008 - Therapeutic endoscopy plays a major role in the management of gastrointestinal (GI) neoplasia. Its indications can be generalized into four broad categories; to remove or obliterate neoplastic lesion, to palliate malignant obstruction, or to treat...

see more →

Drugs  5 results see all →

Clinicaltrials.gov  61 results

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
https://clinicaltrials.gov/ct2/show/NCT00044304

Jun 24th, 2022 - This study will evaluate the safety and effectiveness of imatinib mesylate in reducing the number of eosinophils (a type of white blood cell) in patients with hypereosinophilic syndrome (HES). Patients with HES have elevated counts of eosinophils ...

Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
https://clinicaltrials.gov/ct2/show/NCT05430841

Jun 24th, 2022 - Subjects with gastrointestinal tumors underwent contemporaneous 18F-AlF-FAPI and 18F-FDG PET/CT either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the maximum standard uptake value (SUVmax). The numbers of...

Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy
https://clinicaltrials.gov/ct2/show/NCT05427227

Jun 22nd, 2022 - The investigators will recruit 500 advancer/late-stage gastrointestinal cancer patients.Blood and tumor tissue will be collected at treatment baseline, every time point response till disease progression. All samples will be processed by exosomes p...

Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
https://clinicaltrials.gov/ct2/show/NCT05182983

Jun 16th, 2022 - The tongue images of patients with gastrointestinal diseases and healthy people will be collected and the tongue image database will be established. Through deep learning and artificial intelligence, early screening models of various gastrointesti...

Treatment of ARB202 Advanced Gastrointestinal Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT05411133

Jun 9th, 2022 - This study aims to find out: The tolerability of ARB202 in adults with advanced solid gastrointestinal tumors who failed the standard treatment. People can participate if their tumor has the CDH17 marker. To find out how study drug is broken down ...

see more →

News  23 results

Average Cumulative Relative Adjuvant Chemo Dose Linked With Survival in CRC
https://www.onclive.com/view/average-cumulative-relative-adjuvant-chemo-dose-linked-with-survival-in-crc

Aug 17th, 2021 - Average cumulative relative dose (ACRD) was found to be associated with survival over average relative dose intensity (ARDI) in patients with colorectal cancer (CRC), highlighting that obese patients receive lower cumulative doses of adjuvant chem...

Optimal Approach Toward Advanced Gastric Cancers in US
https://www.onclive.com/view/optimal-approach-toward-advanced-gastric-cancers-in-us

Apr 2nd, 2021 - Johanna Bendell, MD: In Japan, there are screening protocols that catch these cancers early so they can be cured before they get to an advanced setting. Here in the United States, we don’t have that so much. How are we trying to work to look at ea...

The Evolving Story of Mutational Landscape in Cancer and Its Implications: Bad Luck or Great Hope?
https://www.onclive.com/view/the-evolving-story-of-mutational-landscape-in-cancer-and-its-implications-bad-luck-or-great-hope

Dec 20th, 2020 - Andre Goy, MD Editor-in-Chief of Oncology & Biotech News Chairman and Director Chief of Lymphoma Director, Clinical and Translational Cancer Research John Theurer Cancer Center at Hackensack University Medical Center While it is...

Survival Benefit Observed With Cetuximab in RAS Wild-Type Colorectal Cancer
https://www.onclive.com/view/survival-benefit-observed-with-cetuximab--in-ras-wild-type-colorectal-cancer

Dec 20th, 2020 - Volker Heinemann, MD, PhD Cetuximab (Erbitux) plus FOLFIRI may offer a survival advantage over FOLFIRI plus bevacizumab (Avastin) in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer who do not have RAS mu...

Regorafenib Extends PFS in Locally Advanced Biliary Tract Cancer
https://www.onclive.com/view/regorafenib-extends-pfs-in-locally-advanced-biliary-tract-cancer

Dec 20th, 2020 - The oral multi-kinase inhibitor regorafenib extended progression-free survival (PFS) in patients with metastatic or unresectable biliary tract cancer (BTC) who were previously treated with gemcitabine (Gemzar) and a platinum-based chemotherapy, ac...

see more →